Medical Professionals:
Request a
Product Sample
We want to continuously educate the public about our innovative products and want to bring you what the media thinks of HemCon and its products.

On this page you can find a variety of resources including:
 Featured Press Releases   |   See All Press Releases >

Tricol International Group Limited Completes Asset Acquisition of HemCon Medical Technologies Inc.
Global microfiber expert to stabilize and focus growth of Oregon based advanced wound care company

HemCon Medical Technologies, Inc. to Transition to New Ownership
Company to be acquired and reorganized under new ownership

Collaboration Between HemCon and OHSU is Awarded Additional NIH Grant with Total Value of $1.1M for the Development of a Transurethral Hemostatic Device

HemCon Medical Technologies Launches into Chinese Market

HemCon Medical Technologies, Inc Receives 2015 Best of Portland Award

HemCon Joins aptitude LLC for direct contracting value

HemCon Medical Technologies Continues Transition to Innovation Leader

HemCon Medical Technologies, Inc. Awarded Hemostasis and Compression Products Agreement With Premier, Inc.

Ludlow Research Issues Opinion on TriStar Wellness Solutions Based on Pending Q3 Earnings, Valuation

HemCon Medical Technologies, Inc. Projects Strong Third Quarter Revenues
Domestic and International Growth Fuels Continued Innovation

HemCon Medical Technologies, Inc. Announces Strategic Facility Relocation to Support Rapid Growth and New Product Development.
Implementation of a strategic plan to create a prominent medical device technology company

HemCon Medical Technologies, Inc. Announces New Research on ChitoGauze® Published in Leading European Trauma Journal
Use of HemCon’s Hemostatic Technology for Massive Bleeding Control in Dutch Life Flight Helicopters

U.S. Department of Defense's Committee on Tactical Combat Casualty Care (CoTCCC) updated its guideline recommendations to include HemCon's ChitoGauze hemostatic chitosan-coated gauze product

HemCon Medical Technologies Revenue Growth Surges in Japan

HemCon Medical Technologies Launches Online Sales Initiative Offering Innovative Oral Woundcare Technology
Improving HemCon’s Portfolio Accessibility for 180,000 Dentists and Specialists

HemCon Medical Technologies Builds Global Momentum in Dialysis Market
Targeted roll out of innovative dialysis antibacterial hemostat

HemCon Medical Technologies Aims to Capitalize on European Growth

HemCon Expansion into Dental market plus Research Data to Fuel TriStar Wellness Solutions(R) Continued Growth

TriStar Wellness Solutions® Further Expands Patent Portfolio in Asia
 HemCon’s Chitosan Technology now patented in China

TriStar Wellness Solutions® Obtains New Patent for HemCon’s Chitosan Technology in Japan

TriStar Wellness Solutions(R) Receives One Million Dollar Line of Credit

TriStar Wellness Solutions Appoints Wolfgang Henkel as Acting Managing Director, HemCon Medical Technologies European Subsidiary Proven Industry Leader Will Shape the Future of the Hemcon EU Business

TriStar Wellness Solutions Initiates National Sales Force and Marketing Communications for HemCon Medical Technologies Subsidiary

TriStar Wellness Solutions Obtains U.S. Patent for Manufacturing Process for m.doc™ Bleeding Control Technology Company Plans Comprehensive Launch of m.doc™ Product Line in U.S. OTC Market

TriStar Wellness Solutions Acquires HemCon Medical Technologies
Developer of Bleeding and Wound Management Technologies for Surgical, Health Care, Consumer and Military Markets to Operate as Wholly Owned Subsidiary of TriStar Wellness Solutions